Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers

T.-Y. Wei, C.-C. Wang
  • Alimentary Pharmacology & Therapeutics (Suppl), December 2016, Wiley
  • DOI: 10.1111/apt.13829

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/apt.13829

The following have contributed to this page: Chia-Chi Wang

In partnership with:

Contributors